Exact Mass: 426.0929
Exact Mass Matches: 426.0929
Found 366 metabolites which its exact mass value is equals to given mass value 426.0929
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Anhydrotetracyclin
Cysteineglutathione disulfide
Cysteineglutathione disulfide is a molecule that is formed upon oxidative stress of glutathione, that will form mixed disulfides with protein thiol groups, causing reversible S-glutathionylation. S-glutathionylation is an important post-translational modification responsible for transducing oxidant signals. S-glutathionylation of thiols confers protection against their irreversible oxidation, like for instance the formation of sulphonic acid moieties. If the targeted cysteine is a functionally critical amino acid, S-glutathionylation will however also modify protein function. (PMID 16515838). S-sulfonation and S-thiolation of transthyretin Phe33Cys has been detected in a patient with familial transthyretin amyloidosis. (PMID 12876326). In Cystinotic human skin fibroblasts in tissue culture there is an accumulation of cystine. Stored cystine in cystinotic tissues may derive in part from glutathione-cysteine mixed disulfide via transpeptidation. (PMID 6130452). Cystinosis is an autosomal recessive disorder caused by an impaired transport of cystine out of lysosomes. (PMID 15042893). Cysteineglutathione disulfide is a molecule that is formed upon oxidative stress of glutathione, that will form mixed disulfides with protein thiol groups, causing reversible S-glutathionylation. [HMDB]
Mometasone
Mometasone is a medium-potency synthetic corticosteroid with antiinflammatory, antipruritic, and vasoconstrictive properties. Studies in asthmatic patients have demonstrated that mometasone provides a favorable ratio of topical to systemic activity due to its primary local effect along with the extensive hepatic metabolism and the lack of active metabolites. Though effective for the treatment of asthma, glucocorticoids do not affect asthma symptoms immediately. Maximum improvement in symptoms following inhaled administration of mometasone furoate may not be achieved for 1 to 2 weeks or longer after starting treatment. he antiinflammatory actions of corticosteroids are thought to involve phospholipase A2 inhibitory proteins, lipocortins, which control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes. D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07X - Corticosteroids, other combinations > D07XC - Corticosteroids, potent, other combinations R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03B - Other drugs for obstructive airway diseases, inhalants > R03BA - Glucocorticoids D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AC - Corticosteroids, potent (group iii) R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AD - Corticosteroids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D000893 - Anti-Inflammatory Agents D018926 - Anti-Allergic Agents D003879 - Dermatologic Agents
fluacrypyrim
Nicarbazin
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents
(-)-Epiafzelechin 3-gallate
(-)-Epiafzelechin 3-gallate is found in tea. (-)-Epiafzelechin 3-gallate is isolated from Camellia sinensis var. assamica (oolong tea). Isolated from Camellia sinensis variety assamica (oolong tea). (-)-Epiafzelechin 3-gallate is found in tea.
Butanoic acid, 3-((2-naphthalenylsulfonyl)amino)-4-oxo-4-((2-phenylethyl)amino)-, (S)-
(3-(2-(4-(2-(Trifluoromethyl)phenoxy)piperidin-1-yl)thiazol-5-yl)-1,2,4-oxadiazol-5-yl)methanol
Cysteine-glutathione disulfide
Diflunisal glucuronide ester
D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates
Diflunisal glucuronide ether
D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates
Fevipiprant
D006133 - Growth Substances > D010937 - Plant Growth Regulators > D007210 - Indoleacetic Acids C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent C177182 - Prostaglandin Receptor Antagonist
Garenoxacin
Lenvatinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents
Hydroxy-2-naphthalenylmethylphosphonic acid tris-acetoxymethyl ester
Vericiguat
Villosinol
11-Hydroxytephrosin
8-Deoxy-15-(3-hydroxy-2-methyl-propanoyl)-lactucin-3-sulfate
5-Hydroxy-8-(4-hydroxy-3,5-dimethoxyphenyl)-10-methoxy-2,2-dimethyl-2H,6H-benzo[1,2-b:5,4-b]dipyran-6-one
5-Hydroxy-3,8-dimethoxy-3,4-methylenedioxy-7-prenyloxyflavone
N-Fructosyl gamma-glutamyl-S-methylcysteine
Annotation level-3
(-)-sanguinolignan D|(8R,7S,8S)-7-acetoxy-3,3,4,4-bis(methylenedioxy)-7-oxolignano-9,9-lactone
2-(3,4-Dihydroxyphenyl)-3-(2,4,6-trihydroxyphenyl)-5,7-dihydroxy-2,3-epoxy-3,4-dihydro-2H-1-benzopyran-4-one
5,7-Diacetoxy-3-(4-acetoxy-phenyl)-6-methoxy-chromen-4-on|5,7-diacetoxy-3-(4-acetoxy-phenyl)-6-methoxy-chromen-4-one
N,2,3,5-Tetra-Ac-beta-D-5-Amino-1-ribofuranosyl-1H-imidazole-4-carboxamide
2-acetyl-1,3-dicoumaroylglycerol|2-acetyl-1,3-di[(E)-p-coumaroyl]glycerol|Lasiocarpin A
(1R,2S,3R,4S)-1-Ac,1,3-debenzoyl-5-(Hydroxymethyl)-5-cyclohexene-1,2,3,4-tetrol|acetyl piperenol A
uvarirufol B|{(1R,4S,5R,6S)-6-acetoxy-1,4-dihydroxy-5-[(benzoyl)oxy]cyclohex-2-en-1-yl}methyl benzoate
9alpha,11-dihydroxy-13-chloro-11,13-dihydroatripliciolide-8-O-angelate
11-(3-carboxy-3-hydroxy-propionyl)-5-hydroxy-1-oxo-1,12-dihydro-4H-pyrido[3,2-a]phenoxazine-3-carboxylic acid|alpha-hydroxy-alpha-deamino-dihydro-xanthommatin|Rhodommatin
8-Me ehter,tri-Ac-1,3,5,8-Tetrahydroxy-2-methylanthraquinone
3,4,5-trimetoxyphenil 1-O-beta-(6-sulpho)-glucopyranoside
(-)-6-acetylzeylenol|(-)-6-O-acetyl-1-benzoyloxymethylcyclohex-4-en-1,2,3,6-tetrol
(5E,8Z,14Z)-6-iodoicosa-5,8,14,19-tetraen-11-ynoic acid
2-(1,3-Benzodioxole-5-yl)-3,5-dimethoxy-7-(2-hydroxy-3-methyl-3-butenyloxy)-4H-1-benzopyran-4-one
5-O-beta-D-glucopyranosyl-1,3,8-trihydroxy-5,6,7,8-tetrahydroxanthone
(-)-deguoic acid|5-(6,7-dimethoxy-2,3-dihydrochromon-3-oxy) beta-tubaic acid
(-)-rotoic acid|4-(2,3-dihydro-6,7-dimethoxychromon-3-oxy) tubaic acid
3-Carboxy-6,7-dihydroxy-1-(3,4-dihydroxyphenyl)-naphthalene-9,2-O-malic acid ester
19-Ac-(ent-4beta,7alpha,12betaH)-18-Chloro-15,16-epoxy-4,7,19-trihyrdroxy-3,6-dioxo-13(16),14-clerodadien-20,12-olide
Ala Cys Cys Met
Ala Cys Met Cys
Ala Met Cys Cys
Cys Ala Cys Met
Cys Ala Met Cys
Cys Cys Ala Met
Cys Cys Cys Val
Cys Cys Asp Ser
Cys Cys Met Ala
Cys Cys Ser Asp
Cys Cys Thr Thr
Cys Cys Val Cys
Cys Asp Cys Ser
Cys Asp Ser Cys
Cys Met Ala Cys
Cys Met Cys Ala
Cys Met Ser Ser
Cys Ser Cys Asp
Cys Ser Asp Cys
Cys Ser Met Ser
Cys Ser Ser Met
Cys Thr Cys Thr
Cys Thr Thr Cys
Cys Val Cys Cys
Asp Cys Cys Ser
Asp Cys Ser Cys
Asp Ser Cys Cys
Met Ala Cys Cys
Met Cys Ala Cys
Met Cys Cys Ala
Met Cys Ser Ser
Met Ser Cys Ser
Met Ser Ser Cys
Ser Cys Cys Asp
Ser Cys Asp Cys
Ser Cys Met Ser
Ser Cys Ser Met
Ser Asp Cys Cys
Ser Met Cys Ser
Ser Met Ser Cys
Ser Ser Cys Met
Ser Ser Met Cys
Thr Cys Cys Thr
Thr Cys Thr Cys
Thr Thr Cys Cys
Val Cys Cys Cys
Anhydrotetracycline
2,2-(5-Bromo-2-fluoro-1,3-phenylene)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane)
(3-ETHOXYCARBONYL-2-OXOPROPLY)TRIPHENYLPHOSPHONIUM CHLORIDE
Fenbenicillin
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Thioacetic acid S-[4-[4-(4-acetylsulfanylphenylethynyl)-phenylethynyl]-phenyl] ester
methyl N-[4-[2-[(5-chloro-2-methoxybenzoyl)amino]ethyl]phenyl]sulfonylcarbamate
1,2,3,4,5,6-Benzenehexacarboxylicacid, 1,2,3,4,5,6-hexamethyl ester
(r)-5-bromo-3-[(1-methyl-2-pyrrolidinyl)methyl]-1h-indole
Garenoxacin
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors
2-(4-methoxyphenyl)-4,6-diphenylpyrylium tetrafluoroborate
bis(trifluoromethylsulfonyl)azanide,diethyl-(2-methoxyethyl)-methylazanium
benzyl 2-(5-bromo-1H-indole-3-carbonyl)pyrrolidine-1-carboxylate
2,4-DIFLUORO-N-(2-METHOXY-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-3-YL)BENZENESULFONAMIDE
U0126-EtOH
U0126 (U0126-EtOH) is a potent, non-ATP competitive and selective MEK1 and MEK2 inhibitor, with IC50s of 72 nM and 58 nM, respectively. U0126 is an autophagy and mitophagy inhibitor[1][2][3][4].
p-Nitrophenyl 2-Acetamido-2-deoxy-3,6-di-O-acetyl-β-D-glucopyranoside
5-(2-Fluoro-3-methoxyphenyl)-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl-2,4(1H,3H)-pyrimidinedione
.beta.-D-Glucopyranosiduronic acid, phenyl 1-thio-, methyl ester, triacetate
ICI 199,441 hydrochloride
ICI 199441 is a potent and selective κ-opioid receptor agonist. ICI 199441 can improve heart resistance to ischemia/reperfusion[1].
Pregna-1,4-diene-3,20-dione,9,11-dichloro-17,21-dihydroxy-16-methyl-, (11b,16a)-
4-Epianhydrotetracycline
4-Epianhydrotetracycline. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=7518-17-4 (retrieved 2024-10-30) (CAS RN: 7518-17-4). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
Diethyl 2,4-diacetyl-3-(4-bromophenyl)pentanedioate
Etofamide
P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01A - Agents against amoebiasis and other protozoal diseases > P01AC - Dichloroacetamide derivatives D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
Vericiguat
C - Cardiovascular system > C01 - Cardiac therapy > C01D - Vasodilators used in cardiac diseases COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Afuresertib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C155764 - AKT Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor Afuresertib (GSK2110183) is an orally bioavailable, selective, ATP-competitive and potent pan-Akt kinase inhibitor with Kis of 0.08/2/2.6 nM for Akt1/Akt2/Akt3, respectively[1][2].
1-Cyclopropyl-8-(difluoromethoxy)-7-(1-methylisoindolin-5-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
3-O-methylfluorescein 6-phosphate
D004396 - Coloring Agents > D005456 - Fluorescent Dyes > D005452 - Fluoresceins
2-amino-4-(3-chlorophenyl)-6-(2-furanylmethyl)-7-methyl-5-oxo-4H-pyrano[3,2-c]pyridine-3-carboxylic acid methyl ester
2-[[3-(3,4-dimethoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]thio]-N-(5-methyl-3-isoxazolyl)acetamide
1-[3-({[(4-Amino-5-fluoro-2-methylquinolin-3-YL)methyl]thio}methyl)phenyl]-2,2,2-trifluoroethane-1,1-diol
6-(2,6-Dichlorophenyl)-2-{[3-(hydroxymethyl)phenyl]amino}-8-methylpyrido[2,3-D]pyrimidin-7(8H)-one
N-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}-5-methyl-D-tryptophan
(4AR,6R,7S,8R,8AR)-8-((5R,6R)-3-Carboxy-tetrahydro-4,5,6-trihydroxy-2H-pyran-2-yloxy)-hexahydro-6,7-dihydroxy-2-methylpyrano[3,2-D][1,3]dioxine-2-carboxylic acid)
Lenvatinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents
Fevipiprant
D006133 - Growth Substances > D010937 - Plant Growth Regulators > D007210 - Indoleacetic Acids C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent C177182 - Prostaglandin Receptor Antagonist
4,18-Dihydroxy-15-(3-hydroxy-3-methylbutyl)-2-methoxy-7,9,13-trioxapentacyclo[10.8.0.03,10.04,8.014,19]icosa-1,3(10),5,11,14,16,18-heptaen-20-one
Mefoxin
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002513 - Cephamycins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
(1S,4aS,12aS)-3-carbamoyl-1-(dimethylammonio)-4a,6,7-trihydroxy-11-methyl-4,5-dioxo-1,4,4a,5,12,12a-hexahydrotetracen-2-olate
methyl (2R)-2-ethyl-2,5,7,12-tetrahydroxy-4,6,11-trioxo-1,3-dihydrotetracene-1-carboxylate
(2S)-2-[(2R,3R,4R,5S,6R)-3-[[(2R)-2-amino-3-formylsulfanylpropanoyl]amino]-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutanedioic acid
3-oxo-3-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(7-hydroxy-2-oxochromen-6-yl)oxyoxan-2-yl]methoxy]propanoic acid
(-)-sanguinolignan D
A lignan isolated from the leaves of Piper sanguineispicum.
8-chloro-4-(3-chloro-4-fluoroanilino)-6-(1H-imidazol-5-ylmethylamino)-3-quinolinecarbonitrile
3-(2-fluorophenyl)-6-[4-methoxy-3-(3-oxolanyloxy)phenyl]-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine
3-(2-chlorophenyl)-6-[3-(cyclopropylmethoxy)-4-methoxyphenyl]-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine
5-Chloropyridin-3-yl 1-[(4-methylphenyl)sulfonyl]-1h-indole-5-carboxylate
(E)-N-[[4-(morpholin-4-ylmethyl)phenyl]carbamothioyl]-3-(3-nitrophenyl)prop-2-enamide
7-(4-Chloro-benzyloxy)-2-(3,4-dihydroxy-phenyl)-3,5-dihydroxy-chromen-4-one
7-(3-Chloro-benzyloxy)-2-(3,4-dihydroxy-phenyl)-3,5-dihydroxy-chromen-4-one
3-[[2-[[4-Ethyl-5-[(3-methylphenoxy)methyl]-1,2,4-triazol-3-yl]thio]-1-oxoethyl]amino]benzoic acid
2-[[2-[(3,7-Dimethyl-2-quinolinyl)thio]-1-oxoethyl]amino]-4,5-dimethoxybenzoic acid
N-[5-[(4-chlorophenoxy)methyl]-1,3,4-thiadiazol-2-yl]-5-methyl-3-phenyl-4-isoxazolecarboxamide
N-[4-methyl-3-(1-piperidinylsulfonyl)phenyl]-4-oxo-1-benzopyran-2-carboxamide
2-[[2-[(4-chlorophenyl)thio]-1-oxoethyl]amino]-N-(4-methoxyphenyl)benzamide
N-[3-(1-azepanylsulfonyl)phenyl]-4-oxo-1-benzopyran-2-carboxamide
2-(4-oxo-3-quinazolinyl)-N-[3-(1-piperidinylsulfonyl)phenyl]acetamide
2-[4-(5-{[(2-Methylphenyl)sulfonyl]methyl}-2-furoyl)piperazin-1-yl]pyrimidine
1-(2-Fluorophenyl)-5-[[4-(4-morpholinyl)anilino]methylidene]-2-sulfanylidene-1,3-diazinane-4,6-dione
2-[(5-amino-1-phenacyl-1,2,4-triazol-3-yl)thio]-N-(3-cyano-4,5-dimethyl-2-thiophenyl)acetamide
2-Chloro-N-[(E)-(2-morpholin-4-yl-4-phenyl-1,3-thiazol-5-yl)methylideneamino]benzamide
ethyl (2Z)-2-[(5Z)-3-[2-(furan-2-ylmethylamino)-2-oxoethyl]-5-[(4-methylphenyl)methylidene]-4-oxo-1,3-thiazolidin-2-ylidene]acetate
(1R,5S)-7-[4-(2-fluorophenyl)phenyl]-6-(3-fluorophenyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptane
6-[3-(1,2-Dihydroxybutyl)-1-oxoisochromen-7-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
15-(1,3-Dihydroxy-3-methylbutyl)-18-hydroxy-2-methoxy-7,9,13-trioxapentacyclo[10.8.0.03,10.04,8.014,19]icosa-1,3(10),5,11,14,16,18-heptaen-20-one
1,3,5-Benzenetricarboxylic acid tri(trimethylsilyl) ester
13,21-Dihydroxy-16,17-dimethoxy-6-prop-1-en-2-yl-2,7,20-trioxapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-3(11),4(8),9,14,16,18-hexaen-12-one
2-(4-(4-Nitrophenyl)-6-phenyl-2-pyrimidinylamino)benzoic acid methyl ester
1,2,3-Benzenetricarboxylic acid tri(trimethylsilyl) ester
4,7-DI(Para-methoxyphenyl)-6-(pyridin-4-YL)-1,2,5-thiadiazolo(3,4-C)pyridine
Mometasone
D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07X - Corticosteroids, other combinations > D07XC - Corticosteroids, potent, other combinations R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03B - Other drugs for obstructive airway diseases, inhalants > R03BA - Glucocorticoids D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AC - Corticosteroids, potent (group iii) R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AD - Corticosteroids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D000893 - Anti-Inflammatory Agents D018926 - Anti-Allergic Agents D003879 - Dermatologic Agents
cefoxitin(1-)
A cephalosporin carboxylic acid anion having methoxy, 2-thienylacetamido and carbamoyloxymethyl side-groups, formed by proton loss from the carboxy group of the semisynthetic cephamycin antibiotic cefoxitin.
anhydrotetracycline zwitterion
Zwitterionic form of anhydrotetracycline arising from transfer of a proton from the 2-hydroxy to the tertiary amino group; major species at pH 7.3.
epiafzelechin 3-gallate
A gallate ester obtained by formal condensation of the carboxy group of gallic acid with the (3R)-hydroxy group of epiafzelechin.
L-cysteine glutathione disulfide
An organic disulfide that is the L-cysteinyl derivative of glutathione.
S-butyryl-4-phosphopantetheine(2-)
An S-acyl-4-phosphopantetheine obtained by deprotonation of the phosphate OH groups of S-butyryl-4-phosphopantetheine; major species at pH 7.3.
Keto Ziprasidone
Keto Ziprasidone is an impurity of Ziprasidone[1]. Ziprasidone, an antipsychotic agent, is a combined 5-HT (serotonin) and dopamine receptor antagonist[2].
methyl (1r,2r)-2-ethyl-2,5,7,12-tetrahydroxy-4,6,11-trioxo-1,3-dihydrotetracene-1-carboxylate
(1r,4s,5r,6s)-6-(acetyloxy)-5-[(benzoyloxy)methyl]-4,5-dihydroxycyclohex-2-en-1-yl benzoate
6,6-dichloro-3-methoxy-n,5-dimethyl-n-[2-phenyl-1-(1,3-thiazol-2-yl)ethyl]hex-2-enamide
6-(acetyloxy)-2-[(benzoyloxy)methyl]-4,5-dihydroxycyclohex-2-en-1-yl benzoate
5-(2-hydroxy-1-methanesulfonylpropan-2-yl)-10,14-dimethyl-3,6,16-trioxapentacyclo[8.6.1.0²,⁴.0⁴,⁹.0¹⁴,¹⁷]heptadec-8-ene-7,15-dione
(1r,14r)-11,14-dihydroxy-17,18-dimethoxy-7,7-dimethyl-2,8,21-trioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁵,²⁰]docosa-3,5,9,11,15(20),16,18-heptaen-13-one
6-[(6,8-dihydroxy-3,7-dimethyl-1-oxo-3,4-dihydro-2-benzopyran-5-yl)methyl]-5-hydroxy-7-methoxy-2-methylchromen-4-one
6-{[(3r)-6,8-dihydroxy-3,7-dimethyl-1-oxo-3,4-dihydro-2-benzopyran-5-yl]methyl}-5-hydroxy-7-methoxy-2-methylchromen-4-one
[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-(3,4,5-trimethoxyphenoxy)oxan-2-yl]methoxysulfonic acid
2-(2h-1,3-benzodioxol-5-yl)-5-hydroxy-3,8-dimethoxy-7-[(3-methylbut-2-en-1-yl)oxy]chromen-4-one
(2r,2's,4s,6s,7s,10s,12s)-2',12,17-trihydroxy-6-methyl-3,8-dioxaspiro[hexacyclo[11.8.0.0²,⁴.0²,¹⁰.0⁶,¹⁰.0¹⁴,¹⁹]henicosane-7,3'-oxolane]-1(13),14,16,18-tetraene-5',20-dione
5,7-dihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate
(2z,4s,7r,8s,9s,10r,11r)-7-(chloromethyl)-7,10-dihydroxy-2,11-dimethyl-6,12-dioxo-5,14-dioxatricyclo[9.2.1.0⁴,⁸]tetradeca-1(13),2-dien-9-yl (2z)-2-methylbut-2-enoate
11-hydroxytephrosin
{"Ingredient_id": "HBIN000455","Ingredient_name": "11-hydroxytephrosin","Alias": "NA","Ingredient_formula": "C23H22O8","Ingredient_Smile": "CC1(C=CC2=C(O1)C=C(C3=C2OC4COC5=CC(=C(C=C5C4(C3=O)O)OC)OC)O)C","Ingredient_weight": "426.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10740","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "124355889","DrugBank_id": "NA"}
4',5',7-triacetoxy-2'-methoxyisoflavone
{"Ingredient_id": "HBIN009982","Ingredient_name": "4',5',7-triacetoxy-2'-methoxyisoflavone","Alias": "NA","Ingredient_formula": "C22H18O9","Ingredient_Smile": "CC(=O)OC1=CC2=C(C=C1)C(=O)C(=CO2)C3=CC(=C(C=C3OC)OC(=O)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21512","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}